Grant: Discovery Grants Program - Individual
McGill University
$30,000.00
Leptin as a modulator of glial activity in inflammation
EF 2013-14
Résumé
Communication between the immune system and the brain is a critical process governing our ability to respond to and mount an effective defense response against invading pathogens. Peripheral immune mediators known as cytokines (e.g. interleukin-1) play an important role in this communication through direct actions in the brain. We have shown previously that a new member of this family, leptin, which is mainly produced by fat in proportion to its mass, and is involved principally in controlling body weight by suppressing appetite, stimulates the production of cytokines in the brain and may act as a new circulating messenger during disease. In addition to inhibiting appetite we also reported, for the first time, that leptin induces fever, which is a hallmark for disease and that leptin is integral to the body's defense mechanisms against bacterial infection and inflammation. Our latest discoveries indicate that the role of this cytokine like hormone in immunity is more complex than first envisaged and rather than acting directly on brain targets of inflammation it instead facilitates the action of other inflammatory molecules by regulating the state of readiness of the resident immune cells in the brain, namely microglia. We have discovered that the action of leptin on these cells makes them more likely to respond to an inflammatory stimulus efficiently. The work described in the current proposal will investigate this mechanism by posing the hypothesis that the role of leptin in immunity is that of a modulator of immune cell activity in the brain, which may include anti-apoptotic activity. Because circulating leptin levels fluctuate across a multitude of conditions (e.g. obesity, anorexia) a role for this hormone in modulating immune cell function in the brain could have wide-ranging implications for neuro-inflammatory responses. Thus to address this hypothesis we will conduct both in vivo and in vitro approaches in rodents to explore the underlying mechanisms responsible for the actions of leptin on microglial cells in the brain and in particular focus on the receptors involved and on how the fluctuation of circulating leptin levels can influence these effects.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
238546-2013
Name nom
Luheshi, Giamal
Department département
Psychiatry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
30000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
1
Nb partie
1
Application title
Leptin as a modulator of glial activity in inflammation
Keyword
NSERC
Application summary
Communication between the immune system and the brain is a critical process governing our ability to respond to and mount an effective defense response against invading pathogens. Peripheral immune mediators known as cytokines (e.g. interleukin-1) play an important role in this communication through direct actions in the brain. We have shown previously that a new member of this family, leptin, which is mainly produced by fat in proportion to its mass, and is involved principally in controlling body weight by suppressing appetite, stimulates the production of cytokines in the brain and may act as a new circulating messenger during disease. In addition to inhibiting appetite we also reported, for the first time, that leptin induces fever, which is a hallmark for disease and that leptin is integral to the body's defense mechanisms against bacterial infection and inflammation. Our latest discoveries indicate that the role of this cytokine like hormone in immunity is more complex than first envisaged and rather than acting directly on brain targets of inflammation it instead facilitates the action of other inflammatory molecules by regulating the state of readiness of the resident immune cells in the brain, namely microglia. We have discovered that the action of leptin on these cells makes them more likely to respond to an inflammatory stimulus efficiently. The work described in the current proposal will investigate this mechanism by posing the hypothesis that the role of leptin in immunity is that of a modulator of immune cell activity in the brain, which may include anti-apoptotic activity. Because circulating leptin levels fluctuate across a multitude of conditions (e.g. obesity, anorexia) a role for this hormone in modulating immune cell function in the brain could have wide-ranging implications for neuro-inflammatory responses. Thus to address this hypothesis we will conduct both in vivo and in vitro approaches in rodents to explore the underlying mechanisms responsible for the actions of leptin on microglial cells in the brain and in particular focus on the receptors involved and on how the fluctuation of circulating leptin levels can influence these effects.